Kexin Liu Selected Research

Collagen

11/2023	Bioactive self-healing umbilical cord blood exosomes hydrogel for promoting chronic diabetic wound healing.
1/2020	Synthesis and biological activity of thieno[3,2-d]pyrimidines as potent JAK3 inhibitors for the treatment of idiopathic pulmonary fibrosis.
10/2019	Hepatoprotection of yangonin against hepatic fibrosis in mice via farnesoid X receptor activation.
9/2016	Protective effects of glycyrrhizic acid from edible botanical glycyrrhiza glabra against non-alcoholic steatohepatitis in mice.
12/2015	Dioscin alleviates alcoholic liver fibrosis by attenuating hepatic stellate cell activation via the TLR4/MyD88/NF-κB signaling pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kexin Liu Research Topics

Disease

50	Neoplasms (Cancer) 01/2024 - 03/2003
40	Inflammation (Inflammations) 01/2024 - 11/2013
12	Breast Neoplasms (Breast Cancer) 01/2023 - 09/2009
11	Non-alcoholic Fatty Liver Disease 12/2023 - 12/2013
10	Cholestasis 09/2021 - 04/2015
9	Reperfusion Injury 09/2023 - 11/2013
9	Acute Kidney Injury (Acute Renal Failure) 09/2022 - 11/2012
7	Body Weight (Weight, Body) 06/2020 - 01/2015
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 01/2016
6	Wounds and Injuries (Trauma) 11/2023 - 01/2015
6	Infections 10/2023 - 04/2017
6	Liver Cirrhosis (Hepatic Cirrhosis) 10/2020 - 04/2015
6	Fibrosis (Cirrhosis) 01/2020 - 02/2017
5	Atherosclerosis 12/2023 - 01/2014
5	Necrosis 11/2023 - 06/2009
5	B-Cell Lymphoma (Lymphoma, B Cell) 01/2020 - 01/2018
4	Colonic Neoplasms (Colon Cancer) 02/2024 - 01/2014
4	Hypercholesterolemia 12/2023 - 01/2019
4	Obesity 12/2023 - 01/2015
4	Rheumatoid Arthritis 01/2022 - 01/2016
4	Hepatocellular Carcinoma (Hepatoma) 09/2021 - 01/2014
4	Lung Neoplasms (Lung Cancer) 01/2020 - 09/2013
4	Hypoxia (Hypoxemia) 03/2019 - 10/2015
4	Insulin Resistance 02/2019 - 07/2017
4	Hepatitis 03/2013 - 07/2008
3	Alcoholic Fatty Liver 05/2024 - 09/2016
3	Colorectal Neoplasms (Colorectal Cancer) 01/2024 - 01/2014
3	Neoplasm Metastasis (Metastasis) 09/2022 - 11/2014
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2022 - 01/2015
3	Lymphoma (Lymphomas) 01/2020 - 07/2017
3	Liver Diseases (Liver Disease) 04/2018 - 12/2017
3	Pancreatic Neoplasms (Pancreatic Cancer) 12/2017 - 01/2017
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 07/2017 - 01/2015
2	Lipid Metabolism Disorders (Metabolism Disorders, Lipid) 05/2024 - 02/2023
2	Fatty Liver 05/2024 - 01/2015
2	Enteritis 02/2024 - 01/2023
2	Hypersensitivity (Allergy) 11/2023 - 11/2023
2	Anaphylaxis (Anaphylactic Shock) 11/2023 - 06/2023

Drug/Important Bio-Agent (IBA)

29	dioscinIBA 05/2023 - 05/2013
14	Proteins (Proteins, Gene)FDA Link 06/2023 - 09/2010
10	Interleukin-6 (Interleukin 6)IBA 12/2021 - 12/2015
9	Therapeutic UsesIBA 02/2024 - 11/2014
9	EnzymesIBA 01/2024 - 11/2016
8	Biomarkers (Surrogate Marker)IBA 03/2024 - 11/2015
8	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 05/2013
8	JBP 485IBA 03/2019 - 07/2008
7	CholesterolIBA 01/2024 - 01/2015
7	Small Interfering RNA (siRNA)IBA 02/2022 - 07/2015
7	Bile Acids and Salts (Bile Acids)IBA 09/2021 - 01/2017
6	Cisplatin (Platino)FDA LinkGeneric 09/2022 - 11/2012
6	Messenger RNA (mRNA)IBA 02/2022 - 04/2015
6	yangoninIBA 09/2021 - 01/2018
6	LipidsIBA 09/2021 - 01/2014
6	AntioxidantsIBA 06/2020 - 02/2013
5	LipopolysaccharidesIBA 01/2024 - 12/2015
5	CollagenIBA 11/2023 - 12/2015
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023 - 06/2009
5	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2022 - 01/2015
4	GlucocorticoidsIBA 12/2023 - 01/2019
4	EpitopesIBA 11/2023 - 01/2022
4	Peptides (Polypeptides)IBA 11/2023 - 01/2016
4	Dexamethasone (Maxidex)FDA LinkGeneric 12/2022 - 01/2020
4	Glycyrrhizic Acid (Glycyrrhizin)IBA 08/2022 - 09/2016
4	LuteolinIBA 01/2022 - 01/2014
4	SolutionsIBA 10/2020 - 01/2013
4	Insulin (Novolin)FDA Link 06/2020 - 02/2015
4	pyrimidineIBA 01/2020 - 01/2018
4	catalpolIBA 01/2020 - 01/2018
4	Gefitinib (Iressa)FDA Link 12/2018 - 03/2016
4	Glucose (Dextrose)FDA LinkGeneric 02/2018 - 02/2015
4	Docetaxel (Taxotere)FDA Link 09/2016 - 09/2009
4	Succinic Acid (Succinate)IBA 01/2016 - 05/2010
4	tocophersolanIBA 08/2015 - 05/2010
3	FructoseIBA 05/2024 - 03/2018
3	NF-kappa B (NF-kB)IBA 01/2024 - 03/2018
3	Immunoglobulin E (IgE)IBA 11/2023 - 01/2022
3	DNA (Deoxyribonucleic Acid)IBA 11/2023 - 03/2003
3	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2023 - 01/2021
3	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2014
3	Triglycerides (Triacylglycerol)IBA 01/2021 - 01/2015
3	Streptozocin (Streptozotocin)FDA Link 01/2021 - 02/2015
3	spebrutinibIBA 01/2020 - 01/2017
3	ibrutinibIBA 01/2020 - 01/2018
3	Thioacetamide (Thioacetamid)IBA 10/2019 - 04/2015
3	Estrogens (Estrogen)FDA Link 10/2019 - 07/2019
3	Acetaminophen (Paracetamol)FDA LinkGeneric 10/2018 - 05/2014
3	HMGB1 Protein (HMG1)IBA 03/2018 - 01/2017
3	Agammaglobulinaemia Tyrosine KinaseIBA 07/2017 - 01/2017
3	polyethylene glycol 1000IBA 01/2016 - 05/2010
3	SaponinsIBA 02/2015 - 04/2014
3	FlavonoidsIBA 12/2013 - 02/2013
3	Poloxamer (Poloxamer 407)IBA 06/2010 - 09/2009
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 02/2024 - 10/2023
2	CytokinesIBA 01/2024 - 12/2021
2	HydrogelsIBA 11/2023 - 11/2014
2	Caffeine (No Doz)FDA LinkGeneric 11/2023 - 01/2019
2	LigandsIBA 10/2023 - 09/2010

Therapy/Procedure

19	Therapeutics 01/2023 - 06/2010
16	Drug Therapy (Chemotherapy) 02/2024 - 09/2009
2	Immunotherapy 01/2024 - 10/2023